- Home
- SILO vs ENVB Comparison
SILO vs ENVB Comparison
Compare SILO & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- ENVB
- Stock Information
- Founded
- SILO 2010
- ENVB 1994
- Country
- SILO United States
- ENVB United States
- Employees
- SILO N/A
- ENVB N/A
- Industry
- SILO Apparel
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- ENVB Health Care
- Exchange
- SILO Nasdaq
- ENVB Nasdaq
- Market Cap
- SILO 3.1M
- ENVB 3.2M
- IPO Year
- SILO N/A
- ENVB N/A
- Fundamental
- Price
- SILO $0.58
- ENVB $1.30
- Analyst Decision
- SILO
- ENVB Strong Buy
- Analyst Count
- SILO 0
- ENVB 1
- Target Price
- SILO N/A
- ENVB $10.00
- AVG Volume (30 Days)
- SILO 2.4M
- ENVB 461.6K
- Earning Date
- SILO 05-09-2025
- ENVB 05-14-2025
- Dividend Yield
- SILO N/A
- ENVB N/A
- EPS Growth
- SILO N/A
- ENVB N/A
- EPS
- SILO N/A
- ENVB N/A
- Revenue
- SILO $72,102.00
- ENVB N/A
- Revenue This Year
- SILO $1.86
- ENVB N/A
- Revenue Next Year
- SILO N/A
- ENVB N/A
- P/E Ratio
- SILO N/A
- ENVB N/A
- Revenue Growth
- SILO N/A
- ENVB N/A
- 52 Week Low
- SILO $0.41
- ENVB $1.01
- 52 Week High
- SILO $4.50
- ENVB $11.82
- Technical
- Relative Strength Index (RSI)
- SILO 45.16
- ENVB 45.17
- Support Level
- SILO $0.43
- ENVB $1.11
- Resistance Level
- SILO $0.49
- ENVB $1.34
- Average True Range (ATR)
- SILO 0.06
- ENVB 0.10
- MACD
- SILO 0.03
- ENVB 0.04
- Stochastic Oscillator
- SILO 45.03
- ENVB 70.26
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.